Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

Delayed Data
As of Oct 21
 -0.36 / -1.11%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Major

Company Description

Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. Pfizer was founded by Charles Pfizer Sr. and Charles H. Erhart Jr. in 1849 and is headquartered in New York, NY.

Contact Information

Pfizer Inc.
235 East 42nd Street
New York New York 10017-5755
P:(212) 733-2323
Investor Relations:
(132) 733-3901



Mutual fund holders36.85%
Other institutional36.13%
Individual stakeholders0.24%

Top Executives

Ian C. ReadChairman & Chief Executive Officer
Frank A. D'AmelioChief Financial Officer & EVP-Business Operations
Freda C. Lewis-HallChief Medical Officer & Executive Vice President
Mikael DolstenPresident-Worldwide Research & Development
Ole IsacsonChief Scientific Officer